The antiproliferative effects of γ-tocotrienol have been previously hypothesized to be mediated by the action of γ-tocotrienol to stimulate PPARγ activation by increasing the production of the PPARγ ligand, 15-lipoxygenase-2, in human prostate cancer cells [22]. This evidence concerns the gene PPARG and prostate carcinoma.